Research

Clinical Trials Research

Join the POISE study at Massachusetts General Hospital

Join the study! Researchers have developed POISE, a short program combining palliative and survivorship care…

Irene Guijarro MunozOctober 23, 2025

Research

RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer

The 2025 IASLC World Conference on Lung Cancer was held in Barcelona, Spain, from September…

Irene Guijarro MunozSeptember 12, 2025

Education Research Resources

Announcing the Lung Cancer Genetics Study Database

A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…

Irene Guijarro MunozSeptember 11, 2025

Clinical Trials Research

Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Ellipses’ next generation selective RET inhibitor EP0031 advances to Phase 2 clinical trials in the…

Irene Guijarro MunozJuly 10, 2025

Research

RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)

Irene Guijarro MunozJuly 2, 2025

Research

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)

Irene Guijarro MunozMay 29, 2025

cancer cell lines, breast cancer cell lines, human tumor cell lines, different cell lines, pancreatic cancer

Research

Cancer Cell Lines: Consider Donating to Advance Research

Donating tumor tissue for research can contribute to scientific progress and help others affected by…

Irene Guijarro MunozMay 21, 2025

Research Treatment

2025 IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented in February’s IASLC Targeted Therapies Meeting. March…

Irene Guijarro MunozMarch 20, 2025

Research

A Legacy of Hope in the Fight Against Lung Cancer

What happens when patients lead the way in cancer research? The @23andMe Lung Cancer Genetics…

Irene Guijarro MunozMarch 18, 2025

lung cancer genetic study, lung cancer patients, lung cancer risk

Research

Announcing Lung Cancer Genetics Study & Lifebit Partnership

Lifebit Platform has been selected to power secure data analytics platform for transformative lung cancer…

Irene Guijarro MunozMarch 4, 2025

Join the POISE study at Massachusetts General Hospital

RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer

Announcing the Lung Cancer Genetics Study Database

Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)

Cancer Cell Lines: Consider Donating to Advance Research

2025 IASLC Targeted Therapies Recap

A Legacy of Hope in the Fight Against Lung Cancer

Announcing Lung Cancer Genetics Study & Lifebit Partnership

Popular Posts

Scientific research can be confusing and overwhelming